A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin(®)) as a Resuscitative Agent in Hypovolemic Shock Patients

INTRODUCTION: Centhaquine (Lyfaquin(®)) showed significant safety and efficacy in preclinical and clinical phase I and II studies. METHODS: A prospective, multicentric, randomized phase III study was conducted in patients with hypovolemic shock, systolic blood pressure (SBP) ≤ 90 mmHg, and blood lac...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, Anil, Choudhuri, Rajat, Gupta, Ajay, Singh, Saurabh, Ali, S. K. Noushad, Sidhu, Gursaran Kaur, Haque, Parvez David, Rahate, Prashant, Bothra, Aditya R., Singh, Gyan P., Maheshwari, Sanjiv, Jeswani, Deepak, Haveri, Sameer, Agarwal, Apurva, Agrawal, Nilesh Radheshyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167383/
https://www.ncbi.nlm.nih.gov/pubmed/34061314
http://dx.doi.org/10.1007/s40265-021-01547-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167383/
https://www.ncbi.nlm.nih.gov/pubmed/34061314
http://dx.doi.org/10.1007/s40265-021-01547-5

Ejemplares similares